MHRA Updates
The latest guidances, approvals, and safety alerts from MHRA, curated by automated regulatory intelligence.
Class 4 medicines defect notification submitted by Neuraxpharm UK Limited indicates that a review of the approved Patient Information Leaflet (PIL) has…
Publishes the set of MHRA Field Safety Notices issued between 21 and 25 September 2026, signaling active post-market safety communications that sponsors…
Provides a curated safety update for medicines and medical device users, highlighting the latest safety advice issued by the MHRA.
Notification of a Class 4 defect relating to errors in the Patient Information Leaflet (PIL) for certain batches of meropenem 1000 mg powder and solvent for…
Publishes an MHRA listing of Field Safety Notices issued during 14–18 September 2026, indicating active pharmacovigilance and risk communication activities…
Introduces heightened MHRA safety expectations for wireless cardiotocography (CTG) monitoring systems using RF telemetry channels, focusing on risks of signal…
Reports a Class 4 medicines defect notification to the MHRA concerning an error with the linear barcode for certain batches of Clobazam Martindale Pharma 5…
Highlights ongoing fatal and serious harms from falls during patient transfers/repositioning involving patient hoists and slings, based on incident review and…
Publishes an official bulletin-style listing of Field Safety Notices issued over 7–11 September 2026, signalling active MHRA safety communications to industry…
Publishes a list of MHRA Field Safety Notices issued between 31 August and 4 September 2026, signalling ongoing post-market safety communications that may…
Publishes a weekly list of MHRA Field Safety Notices issued between 24 and 28 August 2026, which may indicate ongoing device safety actions across the market.
Requires that filters be used during the administration of parenteral nutrition across all care settings to mitigate risks of serious adverse incidents.
Highlights MHRA safety concerns for cobalt-chrome modular neck hip stem components, citing increased wear and corrosion risks that could translate into a…
Summarises MHRA’s latest safety-related advice affecting how medicines and medical device users should interpret ongoing risk information.
Withdrawal from the UK market of the NGPod handheld pH testing device (NGPod handheld device and NGPod sensor) because the manufacturer has ceased trading in…
Compilation of MHRA Field Safety Notices issued between 17 and 21 August 2026, signaling active communications on product-related risks and/or corrective…
Rectal gas and colic reliever catheters sold for personal use are not to be used in infants for any indication, including colic, gas-related discomfort, or…
Initiates a precautionary Class 2 recall of one batch of Fingolimod Zentiva 0.5 mg Capsules due to a potential risk of contamination with metal particles.
Publishes a listing of MHRA Field Safety Notices issued during 10 to 14 August 2026, which may indicate ongoing safety actions affecting marketed products.
Field Safety Notices issued between 13 and 17 July 2026 indicate MHRA communications to support risk awareness and corrective actions for specific product…